These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 34294235)

  • 1. SARS-CoV-2 reinfection.
    Romera I; Núñez K; Calizaya M; Baeza I; Molina R; Morillas J
    Med Intensiva (Engl Ed); 2021; 45(6):375-376. PubMed ID: 34294235
    [No Abstract]   [Full Text] [Related]  

  • 2. Diagnosis value of SARS-CoV-2 antigen/antibody combined testing using rapid diagnostic tests at hospital admission.
    Veyrenche N; Bolloré K; Pisoni A; Bedin AS; Mondain AM; Ducos J; Segondy M; Montes B; Pastor P; Morquin D; Makinson A; Le Moing V; Van de Perre P; Foulongne V; Tuaillon E
    J Med Virol; 2021 May; 93(5):3069-3076. PubMed ID: 33554363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beneficial effect of combinational methylprednisolone and remdesivir in hamster model of SARS-CoV-2 infection.
    Ye ZW; Yuan S; Chan JF; Zhang AJ; Yu CY; Ong CP; Yang D; Chan CC; Tang K; Cao J; Poon VK; Chan CC; Cai JP; Chu H; Yuen KY; Jin DY
    Emerg Microbes Infect; 2021 Dec; 10(1):291-304. PubMed ID: 33538646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serological assay for anti-SARS-CoV-2 antibodies improves sensitivity of diagnosis of COVID-19 patients.
    Rostamzadeh D; Mortezagholi S; Alinejad M; Jooya SR; Eskandarian M; Metvaei A; Vafaei S; Aboulghasemi H; Younesi V; Shabani M
    Med Microbiol Immunol; 2021 Dec; 210(5-6):283-289. PubMed ID: 34564742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Responses to a Neutralizing Monoclonal Antibody for Hospitalized Patients With COVID-19 According to Baseline Antibody and Antigen Levels : A Randomized Controlled Trial.
    ; Lundgren JD; Grund B; Barkauskas CE; Holland TL; Gottlieb RL; Sandkovsky U; Brown SM; Knowlton KU; Self WH; Files DC; Jain MK; Benfield T; Bowdish ME; Leshnower BG; Baker JV; Jensen JU; Gardner EM; Ginde AA; Harris ES; Johansen IS; Markowitz N; Matthay MA; Østergaard L; Chang CC; Goodman AL; Chang W; Dewar RL; Gerry NP; Higgs ES; Highbarger H; Murray DD; Murray TA; Natarajan V; Paredes R; Parmar MKB; Phillips AN; Reilly C; Rupert AW; Sharma S; Shaw-Saliba K; Sherman BT; Teitelbaum M; Wentworth D; Cao H; Klekotka P; Babiker AG; Davey VJ; Gelijns AC; Kan VL; Polizzotto MN; Thompson BT; Lane HC; Neaton JD
    Ann Intern Med; 2022 Feb; 175(2):234-243. PubMed ID: 34928698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unified platform for genetic and serological detection of COVID-19 with single-molecule technology.
    Furth N; Shilo S; Cohen N; Erez N; Fedyuk V; Schrager AM; Weinberger A; Dror AA; Zigron A; Shehadeh M; Sela E; Srouji S; Amit S; Levy I; Segal E; Dahan R; Jones D; Douek DC; Shema E
    PLoS One; 2021; 16(7):e0255096. PubMed ID: 34310620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low risk of reinfections and relation with serological response after recovery from the first wave of COVID-19.
    Peghin M; Bouza E; Fabris M; De Martino M; Palese A; Bontempo G; Graziano E; Gerussi V; Bressan V; Sartor A; Isola M; Tascini C; Curcio F
    Eur J Clin Microbiol Infect Dis; 2021 Dec; 40(12):2597-2604. PubMed ID: 34378086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suboptimal response to combination therapy with tixagevimab/cilgavimab and remdesivir for persistent SARS-CoV-2 infections in immunocompromised patients.
    Wu TY; Chen PY; Wang JT; Liu WD; Chen YC; Chang SC
    J Antimicrob Chemother; 2024 May; 79(5):1196-1200. PubMed ID: 38538154
    [No Abstract]   [Full Text] [Related]  

  • 9. Prolonged SARS-CoV-2 Viral RNA Shedding and IgG Antibody Response to SARS-CoV-2 in Patients on Hemodialysis.
    Shaikh A; Zeldis E; Campbell KN; Chan L
    Clin J Am Soc Nephrol; 2021 Feb; 16(2):290-292. PubMed ID: 33055191
    [No Abstract]   [Full Text] [Related]  

  • 10. Comment on: Suboptimal response to combination therapy with tixagevimab/cilgavimab and remdesivir for persistent SARS-CoV-2 infections in immunocompromised patients.
    Barone F; Giacomelli A; Casalini G; Corbellino M; Lai A; Gori A; Antinori S
    J Antimicrob Chemother; 2024 Sep; 79(9):2400-2402. PubMed ID: 39073825
    [No Abstract]   [Full Text] [Related]  

  • 11. Evaluation of the therapeutic regimen in COVID-19 in transplant patients: where do immunomodulatory and antivirals stand?
    Shafiekhani M; Shahabinezhad F; Niknam T; Tara SA; Haem E; Mardani P; Zare Z; Jafarian S; Mirzad Jahromi K; Arabsheybani S; Moeini YS; Alavi J; Jalali SS; Salimi M; Shahriarirad R; Malekhosseini SA
    Virol J; 2021 Nov; 18(1):228. PubMed ID: 34809657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid Diagnostic Testing for SARS-CoV-2.
    Drain PK
    N Engl J Med; 2022 Jan; 386(3):264-272. PubMed ID: 34995029
    [No Abstract]   [Full Text] [Related]  

  • 13. Evaluation of serum IgM and IgG antibodies in COVID-19 patients by enzyme linked immunosorbent assay.
    Zhou C; Bu G; Sun Y; Ren C; Qu M; Gao Y; Zhu Y; Wang L; Sun L; Liu Y
    J Med Virol; 2021 May; 93(5):2857-2866. PubMed ID: 33331654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Closing the serological gap in the diagnostic testing for COVID-19: The value of anti-SARS-CoV-2 IgA antibodies.
    Infantino M; Manfredi M; Grossi V; Lari B; Fabbri S; Benucci M; Fortini A; Damiani A; Mobilia EM; Panciroli M; Pancani S; Pesce G
    J Med Virol; 2021 Mar; 93(3):1436-1442. PubMed ID: 32790181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serological evaluation of patients with coronavirus disease-2019 in Daegu, South Korea.
    Park S; Chang SH; Lee JH; Lee JH; Ham JY; Kim YK; Kim SG; Ryoo NH
    PLoS One; 2022; 17(1):e0262820. PubMed ID: 35051239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SARS-CoV-2 infection as trigger multisystem inflammatory syndrome?
    Fernández-González SM; Varela-Ferreiro N; Castro Aguiar S; Pardo-Vázquez JJ
    Enferm Infecc Microbiol Clin (Engl Ed); 2021 May; 39(5):262-264. PubMed ID: 33008679
    [No Abstract]   [Full Text] [Related]  

  • 17. Serological investigation of asymptomatic cases of SARS-CoV-2 infection reveals weak and declining antibody responses.
    Yang Y; Wang X; Du RH; Zhang W; Si HR; Zhu Y; Shen XR; Li Q; Li B; Men D; Zhou YN; Wang H; Tong XL; Zhang XE; Shi ZL; Zhou P
    Emerg Microbes Infect; 2021 Dec; 10(1):905-912. PubMed ID: 33870851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Patient with Fever and Dyspnea.
    Matias WR; Vaidya A; Brigl M; Bebell LM
    N Engl J Med; 2020 Nov; 383(19):e111. PubMed ID: 33211933
    [No Abstract]   [Full Text] [Related]  

  • 19. Laboratory divergences in concurrent diagnosis of acute myeloid leukemia relapse and COVID-19: A case report.
    Nizet A; Foguenne J; Gothot A; Tassin F; Keutgens A
    Int J Lab Hematol; 2021 Oct; 43(5):e264-e265. PubMed ID: 33881804
    [No Abstract]   [Full Text] [Related]  

  • 20. Decline and loss of anti-SARS-CoV-2 antibodies in kidney transplant recipients in the 6 months following SARS-CoV-2 infection.
    Chavarot N; Leruez-Ville M; Scemla A; Burger C; Amrouche L; Rouzaud C; Lebreton X; Martinez F; Sberro-Soussan R; Legendre C; Zuber J; Anglicheau D
    Kidney Int; 2021 Feb; 99(2):486-488. PubMed ID: 33509358
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.